1.2% Atorvastatin and 1.2% Simvastatin in Treatment of Chronic Periodontitis
Launched by GOVERNMENT DENTAL COLLEGE AND RESEARCH INSTITUTE, BANGALORE · Feb 9, 2014
Trial Information
Current as of June 14, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Moderate to severe CP subjects with PD ≥ 5 mm or clinical attachment level (CAL) ≥ 4 mm and vertical bone loss ≥3 mm on intraoral periapical radiographs and no history of antibiotic or periodontal therapy in the preceding 6 months
- Exclusion Criteria:
- • Individuals with systemic diseases known to alter the course of periodontal disease and treatment outcome, known or suspected allergy to the SMV/ATV/statin group, those on systemic SMV/ATV/statin therapy, individuals with aggressive periodontitis, use of tobacco in any form, alcoholics, individuals with diabetes, immunocompromised individuals, and pregnant or lactating females
About Government Dental College And Research Institute, Bangalore
The Government Dental College and Research Institute, Bangalore, is a premier academic and research institution dedicated to advancing dental education and clinical practice. Renowned for its commitment to excellence, the institute engages in cutting-edge research and clinical trials aimed at improving oral health outcomes. With a focus on innovative treatment methodologies and evidence-based practices, the institute collaborates with various stakeholders to enhance dental care delivery and promote community health initiatives. Its distinguished faculty and state-of-the-art facilities foster a dynamic environment for the training of future dental professionals and the exploration of groundbreaking dental research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Avani R Pradeep, MDS
Principal Investigator
Professor
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials